The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 10, 2017

Interview with the CEO: Nuvo Pharmaceuticals Inc. (OTCMKTS:NRIFF)

London, John C.
John C. London, LLB, LLM, is Chief Executive Officer of Nuvo Pharmaceuticals Inc. Mr. London has over 30 years of experience managing a wide variety of public and private businesses. Prior to joining Nuvo Pharmaceuticals Inc., Mr. London was Vice Chairman (2005-2009) and then President and Co-CEO (2009-2016) of Nuvo Research Inc., a fully integrated specialty pharmaceutical company with a diverse portfolio of development stage and commercialized products for pain and topical indications. From 2002 to 2005, Mr. London was President and Chief Executive Officer of Powercart Systems Inc., a Canadian-based private company that designs and manufactures battery-equipped workstations that power devices with wireless communication capability. In 1997, Mr. London co-founded Nighthawk Investments, a private venture capital investment firm. In 1994, Mr. London co-founded Triam Automotive Inc., an international automotive parts manufacturer, where he served as Executive Vice President. Triam Automotive Inc. completed its initial public offering in 1994 and was sold to Magna International Inc. in 1998. From 1988 to 1993, he was Executive Vice President, Secretary and General Counsel at Atoma International, Magna International Inc.’s interior systems group. Prior to joining Magna International Inc., Mr. London was a partner with the Toronto law firm of Strathy, Archibald and Seagram — now Gowlings — where from 1981 to 1988 he practiced corporate law with a focus on banking and insolvency. Mr. London is a graduate of the University of Western Ontario law school and holds a Masters of Law degree from University College London. Profile
TWST: Can you tell us briefly about the company? I know that it has gone through some restructuring in the last year or two, so maybe you can explain a little bit about
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy